Investing.com -- GE HealthCare (NASDAQ: GEHC) reported fourth-quarter results that beat analyst expectations, and offered 2026 profit guidance that also exceeded consensus estimates.

The company posted Q4 earnings per share (EPS) of $1.44, topping consensus expectations of $1.40. Revenue came in at $5.7 million, broadly in line with the $5.6 million analysts had forecast.

Quarterly revenue rose 7.1% year-over-year, with organic growth of 4.8%, supported mainly by strength across the U.S. and Europe, the Middle East and Africa.

The company’s shares rose slightly in premarket trading Wednesday.

For the full-year 2025, the company posted revenue growth of 4.8%, including organic growth of 3.5%.

“In our third year as a public company, we’ve made great strides executing our strategy focused on precision care, growth acceleration, and business optimization," said GE HealthCare President and CEO, Peter Arduini.

"We entered 2026 with momentum driven by a differentiated innovation pipeline. While the macro environment remains dynamic, we are focused on delivering profitable growth, strong cash flow, and shareholder value.”

Alongside the results, GE HealthCare introduced its 2026 outlook, forecasting adjusted earnings per share of $4.95 to $5.15, implying year-over-year growth of 7.9% to 12.3%, and above the average analyst estimate of $4.93.

The company expects organic revenue to increase between 3% and 4% in 2026, with adjusted EBIT margins projected at 15.8% to 16.1%, representing an expansion of 50 to 80 basis points.

Adjusted effective tax rate is guided at 20% to 21%, while free cash flow is expected to be around $1.7 billion.

GE HealthCare also said it anticipates tariff-related impacts in 2026 to be lower than in 2025, based on current rates.